# Pregabalin in Preventing Acute Pain Syndrome in Patients Receiving Paclitaxel

> **NCT01637077** · PHASE2 · COMPLETED · sponsor: **Academic and Community Cancer Research United** · enrollment: 46 (actual)

## Conditions studied

- Pain
- Peripheral Neuropathy

## Interventions

- **DRUG:** pregabalin
- **DRUG:** placebo
- **OTHER:** questionnaire administration

## Key facts

- **NCT ID:** NCT01637077
- **Lead sponsor:** Academic and Community Cancer Research United
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-11
- **Final completion:** 2016-04
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2018-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01637077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01637077, "Pregabalin in Preventing Acute Pain Syndrome in Patients Receiving Paclitaxel". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01637077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*